Skip to main content
. Author manuscript; available in PMC: 2009 Apr 2.
Published in final edited form as: Am J Clin Pathol. 2008 May;129(5):815–822. doi: 10.1309/RN84K51B2JJY1Y0B

Table 3.

Stratification of Subjects With or Without Metabolic Syndrome by Number of Metabolic Syndrome Components*

No. of Components
Variable 0 (n = 33) 1 (n = 35) 2 (n = 23) 3 (n = 66) 4 (n = 35) 5 (n = 22) P ANOVA
hsCRP (mg/L) 1.9 ± 0.3 3.2 ± 0.5 4.7 ± 0.5 4.8 ± 0.3 5.2 ± 0.8 5.1 ± 0.8 <.0001
Total adiponectin (μg/mL) 10.03 ± 0.83 7.02 ± 0.45 5.61 ± 0.54 5.65 ± 0.33 4.91 ± 0.35 3.01 ±0.29 <.0001
HMW adiponectin (μg/mL) 5.88 ± 0.64 3.57 ± 0.33 2.57 ± 0.36 2.70 ± 0.25 2.18 ± 0.25 1.06 ± 0.16 <.0001
MMW + LMW adiponectin (μg/mL) 4.15 ± 0.23 3.46 ± 0.16 3.04 ± 0.20 2.95 ± 0.13 2.73 ± 0.18 1.96 ± 0.19 <.0001
SA 0.54 ± 0.02 0.47 ± 0.02 0.41 ± 0.02 0.43 ± 0.02 0.42 ± 0.03 0.35 ± 0.03 .0001
Adiponectin/hsCRP ratio 15.5 ± 3.1 8.1 ± 1.8 2.8 ± 0.6 1.9 ± 0.3 1.6 ± 0.2 0.7 ± 0.1 <.0001
HMW adiponectin/hsCRP ratio 8.68 ± 1.81 4.18 ± 1.04 1.23 ± 0.29 0.95 ± 0.15 0.63 ± 0.09 0.23 ± 0.04 <.0001
MMW + LMW adiponectin/hsCRP ratio 6.82 ± 1.40 3.93 ± 0.83 1.58 ± 0.31 1.02 ± 0.16 0.89 ± 0.16 0.43 ± 0.09 <.0001

ANOVA, analysis of variance; HMW, high-molecular-weight; hsCRP, high-sensitive C-reactive protein; LMW, low-molecular-weight; MMW, medium-molecular-weight; SA, HMW adiponectin/total adiponectin ratio.

*

Data are given as mean ± SEM.

Kruskal-Wallis test.